FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361278503> ?p ?o ?g. }

• W4361278503 endingPage "2033" @default.
• W4361278503 startingPage "2015" @default.
• W4361278503 abstract "Nearly 290000 patients with chronic hepatitis C die annually from the most severe complications of the disease. One of them is liver cirrhosis, which occurs in about 20% of patients chronically infected with the hepatitis C virus (HCV). Direct-acting antivirals (DAAs), which replaced interferon (IFN)-based regimens, significantly improved the prognosis of this group of patients, increasing HCV eradication rates and tolerability of therapy. Our study is the first to assess changes in patient profile, effectiveness, and safety in the HCV-infected cirrhotic population in the IFN-free era.To document changes in patient characteristics and treatment regimens along with their effectiveness and safety profile over the years.The studied patients were selected from 14801 chronically HCV-infected individuals who started IFN-free therapy between July 2015 and December 2021 in 22 Polish hepatology centers. The retrospective analysis was conducted in real-world clinical practice based on the EpiTer-2 multicenter database. The measure of treatment effectiveness was the percentage of sustained virologic response (SVR) calculated after excluding patients lost to follow-up. Safety data collected during therapy and the 12-wk post-treatment period included information on adverse events, including serious ones, deaths, and treatment course.The studied population (n = 3577) was balanced in terms of gender in 2015-2017, while the following years showed the dominance of men. The decline in the median age from 60 in 2015-2016 to 57 years in 2021 was accompanied by a decrease in the percentage of patients with comorbidities and comedications. Treatment-experienced patients dominated in 2015-2016, while treatment-naive individuals gained an advantage in 2017 and reached 93.2% in 2021. Genotype (GT)-specific options were more prevalent in treatment in 2015-2018 and were supplanted by pangenotypic combinations in subsequent years. The effectiveness of the therapy was comparable regardless of the period analyzed, and patients achieved an overall response rate of 95%, with an SVR range of 72.9%-100% for the different therapeutic regimens. Male gender, GT3 infection, and prior treatment failure were identified as independent negative predictors of therapeutic success.We have documented changes in the profile of HCV-infected cirrhotic patients over the years of accessibility to changing DAA regimens, confirming the high effectiveness of IFN-free therapy in all analyzed periods." @default.
• W4361278503 created "2023-03-31" @default.
• W4361278503 creator A5011110351 @default.
• W4361278503 creator A5038698642 @default.
• W4361278503 creator A5039184172 @default.
• W4361278503 creator A5040261650 @default.
• W4361278503 creator A5054816446 @default.
• W4361278503 creator A5055667155 @default.
• W4361278503 creator A5058746547 @default.
• W4361278503 creator A5059817040 @default.
• W4361278503 creator A5067494229 @default.
• W4361278503 creator A5068458474 @default.
• W4361278503 creator A5072918217 @default.
• W4361278503 creator A5083182392 @default.
• W4361278503 creator A5088500414 @default.
• W4361278503 creator A5090001950 @default.
• W4361278503 creator A5090026807 @default.
• W4361278503 creator A5091573769 @default.
• W4361278503 date "2023-04-07" @default.
• W4361278503 modified "2023-10-18" @default.
• W4361278503 title "Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era" @default.
• W4361278503 cites W1984413237 @default.
• W4361278503 cites W2072160870 @default.
• W4361278503 cites W2087582533 @default.
• W4361278503 cites W2127548135 @default.
• W4361278503 cites W2147437748 @default.
• W4361278503 cites W2397044026 @default.
• W4361278503 cites W2406348976 @default.
• W4361278503 cites W2415346488 @default.
• W4361278503 cites W2420900831 @default.
• W4361278503 cites W2435850291 @default.
• W4361278503 cites W2510261413 @default.
• W4361278503 cites W2515727544 @default.
• W4361278503 cites W2588807981 @default.
• W4361278503 cites W2602045128 @default.
• W4361278503 cites W2605861831 @default.
• W4361278503 cites W2617500612 @default.
• W4361278503 cites W2620079105 @default.
• W4361278503 cites W2771909039 @default.
• W4361278503 cites W2782936786 @default.
• W4361278503 cites W2788216918 @default.
• W4361278503 cites W2790932725 @default.
• W4361278503 cites W2805919691 @default.
• W4361278503 cites W2883545166 @default.
• W4361278503 cites W2890297610 @default.
• W4361278503 cites W2908785965 @default.
• W4361278503 cites W2946348481 @default.
• W4361278503 cites W2979520302 @default.
• W4361278503 cites W2983830041 @default.
• W4361278503 cites W2987870062 @default.
• W4361278503 cites W3004888045 @default.
• W4361278503 cites W3005567193 @default.
• W4361278503 cites W3006658062 @default.
• W4361278503 cites W3027214204 @default.
• W4361278503 cites W3028269498 @default.
• W4361278503 cites W3028341895 @default.
• W4361278503 cites W3088020815 @default.
• W4361278503 cites W3092351665 @default.
• W4361278503 cites W3103418183 @default.
• W4361278503 cites W3133542224 @default.
• W4361278503 cites W3135822269 @default.
• W4361278503 cites W3163137890 @default.
• W4361278503 cites W3173694532 @default.
• W4361278503 cites W3173982076 @default.
• W4361278503 cites W3186670979 @default.
• W4361278503 cites W3191150329 @default.
• W4361278503 cites W3211177828 @default.
• W4361278503 cites W4206635732 @default.
• W4361278503 cites W4220657548 @default.
• W4361278503 cites W4229079472 @default.
• W4361278503 cites W4283689432 @default.
• W4361278503 cites W4288058386 @default.
• W4361278503 cites W97688058 @default.
• W4361278503 doi "https://doi.org/10.3748/wjg.v29.i13.2015" @default.
• W4361278503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37155527" @default.
• W4361278503 hasPublicationYear "2023" @default.
• W4361278503 type Work @default.
• W4361278503 citedByCount "1" @default.
• W4361278503 countsByYear W43612785032023 @default.
• W4361278503 crossrefType "journal-article" @default.
• W4361278503 hasAuthorship W4361278503A5011110351 @default.
• W4361278503 hasAuthorship W4361278503A5038698642 @default.
• W4361278503 hasAuthorship W4361278503A5039184172 @default.
• W4361278503 hasAuthorship W4361278503A5040261650 @default.
• W4361278503 hasAuthorship W4361278503A5054816446 @default.
• W4361278503 hasAuthorship W4361278503A5055667155 @default.
• W4361278503 hasAuthorship W4361278503A5058746547 @default.
• W4361278503 hasAuthorship W4361278503A5059817040 @default.
• W4361278503 hasAuthorship W4361278503A5067494229 @default.
• W4361278503 hasAuthorship W4361278503A5068458474 @default.
• W4361278503 hasAuthorship W4361278503A5072918217 @default.
• W4361278503 hasAuthorship W4361278503A5083182392 @default.
• W4361278503 hasAuthorship W4361278503A5088500414 @default.
• W4361278503 hasAuthorship W4361278503A5090001950 @default.
• W4361278503 hasAuthorship W4361278503A5090026807 @default.
• W4361278503 hasAuthorship W4361278503A5091573769 @default.
• W4361278503 hasBestOaLocation W43612785031 @default.
• W4361278503 hasConcept C126322002 @default.

• next